Melbourne-based biotech company Mesoblast announced earlier this week that it’s begun enrolling up to 300 patients for a randomized, controlled study of its stem cell therapy remestemcel-L in the treatment of COVID-19 patients experiencing acute respiratory distress syndrome. Over 20 hospitals will participate in the study, which is anticipated to last 3-4 months. The announcement…
The Latest at Forbes Monaco
Forbes Now
How our oceans are driving the European economy through innovation and sustainable growth. The so-called oyster luge, slurping the brine of the bivalve followed by a smoky sip of single malt scotch, has become something of a stealth hit among elite bars. But that’s not the reason Glenmorangie, the Scottish whisky distiller owned by Louis Vuitton Moet Hennessy (LVMH), started sending divers…
